Gilead Sciences exporting remdesivir, CEO says

Gilead Sciences exporting remdesivir, CEO saysThe head of the maker of remdesivir, an anti-viral shown to reduce recovery times in COVID-19 patients, said Sunday the company has been exporting the drug and is making it available to patients in the United States through the US government. Gilead Sciences CEO Daniel O'Day said the company is donating its entire existing supply of the drug -- 1.5 million vials, enough to treat 100,000 to 200,000 patients. "And our collaboration with the government has been such, we have been very transparent with them here in the United States and we have a good relationship on future allocation."




from Yahoo News - Latest News & Headlines https://ift.tt/2SMdMJ1
via Latest News

Comments

Post a Comment

Popular posts from this blog

Facebook's latest bug exposed the private photos of 6.8 million users - The INQUIRER

Facebook's latest bug exposed the private photos of 6.8 million users    The INQUIRER After a year from hell, Facebook parties like it's 2017    The Guardian Facebook bug may have exposed users’ photos    ConsumerAffairs Bug may have exposed photos from 7 million Facebook users | WSB-TV    WSB Atlanta Use This Tool To See If Your Photos Were Exposed In Facebook's Latest Privacy Blunder    Hot Hardware View full coverage on Google News from Technology - Latest - Google News https://ift.tt/2Bs7iVW via Technology
Read more

Overwatch 2 Anime Charm Is Cheaper In Real Life Than In The Game - Kotaku

Overwatch 2 Anime Charm Is Cheaper In Real Life Than In The Game    Kotaku Blizzard Sells an Overwatch 2 Charm Cheaper in Real Life Than In-Game    IGN Real life Overwatch 2 charm costs less than it does in game    PCGamesN Overwatch 2 Fans Upset at Blizzard's Reasoning for Not Nerfing Sojourn    GameRant Overwatch 2: Keychain Costs More In-Game Than Real Life    DualShockers View Full Coverage on Google News from Technology - Latest - Google News https://ift.tt/P970ArQ via Technology
Read more